These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20158100)

  • 1. [Metabolic syndrome].
    Fukushima Y; Urakaze M; Tobe K
    Nihon Rinsho; 2010 Feb; 68(2):299-304. PubMed ID: 20158100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P
    J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma.
    Pershadsingh HA
    Int J Biochem Cell Biol; 2006; 38(5-6):766-81. PubMed ID: 16298156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D increases PPARγ expression and promotes beneficial effects of physical activity in metabolic syndrome.
    Hoseini R; Damirchi A; Babaei P
    Nutrition; 2017 Apr; 36():54-59. PubMed ID: 28336108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma: its role in metabolic syndrome.
    Pakala R; Kuchulakanti P; Rha SW; Cheneau E; Baffour R; Waksman R
    Cardiovasc Radiat Med; 2004; 5(2):97-103. PubMed ID: 15464947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator.
    Kurtz TW
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S9-16. PubMed ID: 15868121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment strategies for patients with hypertension and insulin resistance.
    Kurtz TW
    Am J Med; 2006 May; 119(5 Suppl 1):S24-30. PubMed ID: 16563944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats.
    Liao J; Soltani Z; Ebenezer P; Isidro-Carrión AA; Zhang R; Asghar A; Aguilar E; Francis J; Hu X; Ferder L; Reisin E
    Nephron Exp Nephrol; 2010; 114(2):e61-8. PubMed ID: 19887847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
    Sil R; Ray D; Chakraborti AS
    Indian J Exp Biol; 2013 Feb; 51(2):129-38. PubMed ID: 23923606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats.
    Seymour EM; Tanone II; Urcuyo-Llanes DE; Lewis SK; Kirakosyan A; Kondoleon MG; Kaufman PB; Bolling SF
    J Med Food; 2011 Dec; 14(12):1511-8. PubMed ID: 21861718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PPARgamma-activating properties of angiotensin receptor blockers].
    Ando H; Fujimura A
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():498-501. PubMed ID: 16895217
    [No Abstract]   [Full Text] [Related]  

  • 16. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
    Fiévet C; Fruchart JC; Staels B
    Curr Opin Pharmacol; 2006 Dec; 6(6):606-14. PubMed ID: 16973418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention.
    Towfighi A; Ovbiagele B
    Cerebrovasc Dis; 2008; 26(2):106-12. PubMed ID: 18560212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ.
    Wang X; Liu J; Long Z; Sun Q; Liu Y; Wang L; Zhang X; Hai C
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):286-96. PubMed ID: 26408789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.
    Jones JR; Barrick C; Kim KA; Lindner J; Blondeau B; Fujimoto Y; Shiota M; Kesterson RA; Kahn BB; Magnuson MA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6207-12. PubMed ID: 15833818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
    Souza-Mello V; Gregório BM; Cardoso-de-Lemos FS; de Carvalho L; Aguila MB; Mandarim-de-Lacerda CA
    Clin Sci (Lond); 2010 Jun; 119(6):239-50. PubMed ID: 20415664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.